Keyphrases
Prime Editing
100%
Recombinase
58%
C-X-C Chemokine Receptor Type 4 (CXCR4)
50%
C-C Chemokine Receptor Type 5 (CCR5)
50%
Co-receptor
50%
Hematopoietic Stem Cells
50%
Base Editing
50%
Primary T Cells
50%
Human Immunodeficiency Virus Type 1 (HIV-1)
50%
Long Genes
50%
Site-specific Integration
50%
Mammalian Cells
50%
Twin Primes
50%
Exon Skipping
50%
Epidermolysis Bullosa
50%
Reinsertion
50%
Collagen VII
50%
Human CD4+ T Cells
37%
DNA Double-strand Breaks
37%
Gene Editing
33%
Integrase Genes
33%
Editing Strategies
33%
Start Codon
25%
COL7A1
25%
Exon 5
25%
Prime Editor
25%
Base Editor
20%
Premature Stop Codon
20%
Bxb1 Recombinase
16%
Targeted Integration
16%
Bxb1
16%
Integration Efficiency
16%
Programmability
16%
Antisense Oligonucleotides
16%
In-frame Deletion
16%
Gene Editing nucleases
16%
Nucleotide Variation
16%
Exon
16%
Locus-specific
16%
Cell Targeting
12%
CCR5-tropic
12%
Viral Vectors
12%
Ablation
12%
CD34+
12%
Engineered T Cells
12%
Human CD4 T Cells
12%
Adenine Base Editor
12%
HIV Co-receptors
12%
Tropics
12%
Point mutation
12%
Biochemistry, Genetics and Molecular Biology
Recombinase
66%
Human Immunodeficiency Virus 1
50%
CXCR4
50%
CCR5
50%
Co-Receptor
50%
T Cell
50%
Hematopoietic Cell
50%
Genome Editing
50%
Exon Skipping
50%
Epidermolysis bullosa
50%
Exon
41%
CD4
33%
Integrase
33%
Double-Strand DNA Break
33%
Stop Codon
25%
Allele
25%
Nuclease
25%
Fibroblast
16%
Start Codon
16%
Wild Type
16%
Oligonucleotide
16%
Antisense
16%
Adenine
8%
CD34
8%
Human Immunodeficiency Virus
8%
Point Mutation
8%
Virus Vector
8%
Transfection
8%
Gene Integration
8%
Bacteriophage
8%
Cytosine
8%
Induced Pluripotent Stem Cell
8%
Genetics
8%
Guide RNA
8%
Keratinocyte
8%
Medicine and Dentistry
Base
60%
Chemokine Receptor CXCR4
50%
Exon Skipping
50%
Exon
50%
Chemokine Receptor CCR5
50%
Epidermolysis Bullosa Dystrophica
50%
Human Immunodeficiency Virus 1
50%
T Cell
50%
Hematopoietic Cell
50%
Double-Strand DNA Break
37%
Nuclease
30%
T-Helper Cell
28%
Stop Codon
24%
Allele
24%
Receptor
21%
Recombinase
20%
Antisense Oligonucleotide
20%
Prematurity
17%
Start Codon
14%
Fibroblast
10%
Therapeutic Agent
10%
Keratinocyte
10%
Epidermolysis bullosa
10%
Induced Pluripotent Stem Cell
10%
Guide RNA
10%
Collagen Type 7
10%
Virus Vector
7%
Infection
7%
Adenine
7%
Point Mutation
7%
Cytosine
7%
Human Immunodeficiency Virus
7%
